Cyprus M&A Playbook 2026 — Share Sale vs Asset Sale, Participation Exemption, Earn-Outs, Warranties

1. Share sale vs asset sale — tax decision

2. The seller's perspective

For a Cyprus tax-resident seller (individual or company), a share sale generally beats an asset sale: 0% capital gains tax on the share disposal under the titles exemption (unless the target's value is >50% Cyprus immovable property — Article 6(1)(a) Capital Gains Tax Law 1980). The seller transfers all the company's liabilities (warranted in the SPA) but extracts 100% of the consideration tax-free.

For a Cyprus-resident COMPANY selling shares in a subsidiary: 0% participation exemption applies unconditionally. For a Cyprus-resident INDIVIDUAL selling shares in a Cyprus Ltd: same 0% on the disposal proceeds (gross, before personal tax on subsequent dividend if proceeds re-invested into Cyprus Ltd).

3. The buyer's perspective

Buyer typically prefers an ASSET sale: clean balance sheet (no inherited liabilities), tax basis step-up enabling depreciation deductions against future profit, ability to cherry-pick assets and contracts. The trade-off: seller pays CIT on the asset uplift, which translates to a higher purchase price for the same net seller proceeds.

Compromise structure: share sale with extensive W&I (Warranties and Indemnities) insurance + comprehensive seller warranties for known liabilities + indemnity for specific tax / employment / regulatory exposures.

4. Earn-out characterisation

Earn-outs (deferred / contingent purchase price linked to target performance) are common in Cyprus M&A. Tax characterisation depends on contract design:

• Pure additional purchase price — characterised as capital, follows the share-sale 0% titles exemption.
• Linked to seller's continued employment — characterised as employment income, taxed at progressive rates (up to 35%).
• Linked to seller's continued advisory services — characterised as service fee, VAT applies if seller is VAT-registered.
• Best practice: separate consideration buckets explicitly in the SPA; pre-clear edge cases via ATR.

5. W&I insurance — Cyprus market practice

Warranties and Indemnities insurance has become standard in mid-market Cyprus M&A (€10M-€100M deals). Typical structure:

• Premium: 1-1.5% of policy limit (typically 10-30% of EV).
• Coverage: 5-7 years standard; 7 years for tax-only sub-limit.
• Excluded: fraud, criminal acts, transactions specifically disclosed in due diligence.
• Used to: cap seller's liability under SPA, accelerate completion (less escrow), reassure buyer.

6. The 90-day Cyprus M&A timeline

1. 1Day 0 — engagement, NDA, indicative term sheet.
2. 2Day 1-30 — due diligence (legal, tax, financial, commercial, regulatory). Cyprus Registrar + Tax Department file reviews. Customer / supplier contracts.
3. 3Day 30-60 — SPA negotiation, W&I insurance binding, regulatory clearances (CySEC if regulated entity, competition authority if thresholds met).
4. 4Day 60-75 — Conditions Precedent satisfied (typically: tax clearance certificate, share-transfer-form preparation).
5. 5Day 75-90 — Completion: share transfer form HE57 filed with Cyprus Registrar, consideration paid, board reconstituted, bank-account signatories updated.
6. 6Post-completion — Cyprus Tax Department notification of change in beneficial ownership (UBO Register update), 30-day SPA disclosure schedule warranties run.

Frequently Asked Questions

Share this article

Disclaimer: This article is for informational purposes only and does not constitute legal, tax, or financial advice. Tax laws change frequently. Consult a qualified Cyprus adviser for guidance specific to your situation. The information on this page is general guidance only and does not constitute legal, tax, accounting, immigration or financial advice. Specific advice should be obtained based on the facts of each case.